However, puerarin treatment greatly reduced cisplatin- increased NF-κB p65 protein expression in COLO205 and HeLa cells (Fig 7), which might exert inhibitory effects on NF-κB signaling pathway and facilitate cisplatin treating cancer more efficiently according to current point of view [58]. Here, NFKB1 is linked to cancer.